Tiagabine Hydrochloride Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Tiagabine Hydrochloride Tablet (tablet) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Apr 15, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 0093-8076-56
- Dosage Form
- Tablet
- Presentation
- Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)
- Initial Posting
- Apr 15, 2026